Sarah Batey

Sarah Batey is currently the Vice President of Project & Portfolio Management at invoX Pharma Limited. Prior to this role, Sarah held various positions at F-star Therapeutics Ltd, Covagen AG, MedImmune, and the University of Cambridge. With a strong background in protein biophysics, Sarah has contributed to the development of bispecific Fynobody for clinical trials and has extensive experience in managing projects and portfolios in the pharmaceutical industry.